F

Fresenius Medical Care

Operates dialysis facilities and renal care

Principal RA Associate Devices

Full-TimeDeadline 11/28/26
$109k - $183k/yr+ Potential performance-based bonus
Senior, Expert
Bachelor's
Waltham, MA, USA
HybridHybrid work arrangement; 10–15% domestic and international travel as required.
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • A bachelor's degree is required; an advanced degree is preferred.
  • At least 8 years of related submission experience is required.
  • Experience interacting effectively with manufacturing, quality, clinical/medical, and marketing departments is required.
  • Prior 510(k) experience is required.
  • Experience with international regulations is preferred.
  • Previous supervisory experience is a plus.
  • Working knowledge of scientific principles is required.
  • Ability to work independently and manage multiple projects is required.
  • Ability to lead projects and manage resource allocation is required.
  • Ability to work effectively in a highly charged, fluid environment is required.
  • Strong attention to detail and organization, and ability to meet deadlines and program goals, are required.
  • Strong verbal and written communication skills, including the ability to make effective and persuasive presentations, are required.
  • Computer skills, including knowledge of Microsoft Office, are required.
Responsibilities
  • Develop regulatory strategies for assigned products and product lines.
  • Prepare regulatory submissions required to market new or modified medical devices in domestic and international clinical markets.
  • Develop and maintain procedures and systems to ensure the product development process addresses regulatory requirements and business objectives.
  • Oversee assigned projects day to day, serving as the primary regulatory resource for project changes, prioritization, resource assignment, and efficient management of development and change processes.
  • Apply professional concepts and broad experience to resolve critical issues and broad design matters.
  • Interpret U.S. and international medical device regulatory requirements and guide product development teams on those requirements.
  • Develop submission strategies for the FDA and other regulatory agencies, and provide regulatory risk assessments and options to product development teams and management.
  • Assist with short- and long-term schedule planning for the product development team.
  • Prepare FDA submissions for new product approvals or clearances, including Premarket Notifications (510(k)s), Premarket Approval Applications (PMAs) and supplements, and Investigational Device Exemption (IDE) submissions.
  • Prepare Regulatory Assessments and Notes to File for assigned projects.
  • Coordinate preparation of additional information and data requested by regulatory agencies and prepare responses to those requests.
  • Independently review and approve relevant documents, including engineering changes, advertising and promotional materials, and product development reports.
  • Develop and maintain regulatory procedures and policies to ensure ongoing compliance of existing and new products.
  • Assist with regulatory agency interactions.
  • Escalate difficult or complex issues to a supervisor or manager when appropriate.
  • Provide leadership and direction to assigned resources and provide timely, appropriate performance feedback.
  • Review and comply with the Code of Business Conduct, applicable company policies and procedures, and local, state, and federal laws and regulations.
  • Assist with projects assigned by a direct supervisor and perform other assigned duties.
  • Travel domestically and internationally 10–15% as required.
Desired Qualifications
  • Experience with international regulations.
  • Previous supervisory experience.

About the company

F

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget
  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...